Searched for
CARBAPENEM RESISTANT INFECTIONS
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...- Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
- 'Nightmare bacteria' cases are increasing in the USA recent report from the Centers for Disease Control and Prevention revealed a significant increase in drug-resistant bacteria infections. ...
- Indian hospitals battle central line infections linked to mismanagement of tubes used for administering medicines and fluidsA seven-year Indian study reveals alarmingly high rates of bloodstream infections from central lines, especially in newborns, with a 40% mo...
- Biotech startup CrisprBits develops platform to test antibiotic resistanceThrough this platform, resistance in bacterial samples can be tested within two hours compared to 24-27 hours through other methods. This c...
- Wockhardt shares rise 10% after Zaynich aids successful liver transplant trialWockhardt's shares surged 8.6% after its antibiotic Zaynich successfully treated a US cancer patient, enabling a liver transplant and chemo...
- Sustained rise in antimicrobial resistance in India: ICMR studyA study by ICMR revealed that Klebsiella pneumoniae and Acinetobacter baumannii showed resistance to imipenem among ICU patients with blood...
- Study flags antimicrobial resistance in bloodstream infections in IndiaA recent study in Lancet Regional Health - Southeast Asia warned that rising antimicrobial resistance (AMR) threatens global health goals b...
- ICMR worried over rising resistance to last-resort antibiotics in IndiaICMR has found the abuse of antimicrobials (antibiotics, antivirals or antifungals) to be the reason for this, which is says has led to wid...
- ICMR issues guidelines against use of antibiotics for low-grade fever"A clinical diagnosis most often helps us predict causative pathogens fitting into a clinical syndrome which would tailor the correct antib...
- Sustained rise in antimicrobial resistance in India: ICMR studyThis is the fifth detailed report on antimicrobial resistance (AMR) trends and patterns from the country published by the ICMR. This year's...
- Livestock with superbugs pose threat to human healthThe study, led by O R Vinodh Kumar, has been peer reviewed and accepted for publication in the Journal of Applied Microbiology.
- 'Superbug from India resistant to all available antibiotics'The infection was caused by carbapenem-resistant Enterobacteriaceae (CRE), a multidrug-resistant organism associated with high mortality.
- ‘Antibiotic addict’ India losing fight against lethal bacteriaThe report confirms the findings of a Princeton University study in 2014 which said Indians consume the highest number of antibiotics in th...
- Common bacteria may become antibiotic-resistant superbugsThe researchers studied a family of bacteria called Enterobacteriaceae, which includes E coli, Klebsiella pneumoniae and Enterobacter.
- Venus Remedies gets European patent for antibiotic drugThe product is designed for mixed multi-drug infections for pediatric, geriatric and adult immuno-compromised patients.
- Drug resistant bugs and evolving infections need to be researchedThe Centre for Disease Control (CDC), USA, believes that a single infectious organism, MRSA, kills more people in the US than AIDS.
- Government to ban over-the-counter sale of 92 antibioticsOver-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs will be clamped down in India soon.
- "Super superbug" NDM-1 spreads in EuropeSome 77 cases of a multi-drug resistant "superbug" from India first reported in Britain in August have now been detected in 13 European cou...
- Venus files patent application for anti-bacterial drugPharmaceutical firm Venus Remedies on Monday said it has filed a patent application for its combination drug for the treatment of multi-bac...
Load More
